X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
humans (16) 16
infectious diseases (11) 11
female (9) 9
male (9) 9
adult (7) 7
hiv (7) 7
infectious disease (7) 7
medicine (7) 7
viruses (7) 7
care and treatment (6) 6
medical research (6) 6
public health (6) 6
virus diseases (6) 6
ebola virus (5) 5
ebola virus infections (5) 5
hiv infection (5) 5
human immunodeficiency virus--hiv (5) 5
kala-azar (5) 5
middle aged (5) 5
mortality (5) 5
research article (5) 5
analysis (4) 4
diagnosis (4) 4
guinea (4) 4
health aspects (4) 4
highly active antiretroviral therapy (4) 4
human immunodeficiency virus (4) 4
human-immunodeficiency-virus (4) 4
immunology (4) 4
liposomal amphotericin-b (4) 4
research (4) 4
therapy (4) 4
tropical diseases (4) 4
viral diseases (4) 4
acquired immune deficiency syndrome--aids (3) 3
africa (3) 3
antiprotozoal agents - therapeutic use (3) 3
cambodia (3) 3
child (3) 3
disease (3) 3
hemorrhagic-fever (3) 3
hiv infections - complications (3) 3
hiv infections - drug therapy (3) 3
hiv patients (3) 3
in-vitro (3) 3
infections (3) 3
leishmaniasis, visceral - diagnosis (3) 3
leishmaniasis, visceral - drug therapy (3) 3
medicine, general & internal (3) 3
multidisciplinary sciences (3) 3
parasitic diseases (3) 3
plasma (3) 3
practice guidelines as topic (3) 3
public, environmental & occupational health (3) 3
resource-limited settings (3) 3
retrospective studies (3) 3
science (3) 3
studies (3) 3
treatment outcome (3) 3
tropical medicine (3) 3
tuberculosis (3) 3
usage (3) 3
viral load (3) 3
virus disease (3) 3
young adult (3) 3
acquired immune deficiency syndrome (2) 2
adolescent (2) 2
adults (2) 2
aids (2) 2
amphotericin b - therapeutic use (2) 2
antiretroviral drugs (2) 2
antiviral agents (2) 2
bacterial diseases (2) 2
biology and life sciences (2) 2
biomarkers (2) 2
biotechnology & applied microbiology (2) 2
body fluids (2) 2
care (2) 2
child, preschool (2) 2
children (2) 2
cohort studies (2) 2
confidence intervals (2) 2
cross-sectional studies (2) 2
death (2) 2
demographic aspects (2) 2
diagnostic medicine (2) 2
disease outbreaks (2) 2
disease transmission (2) 2
double-blind (2) 2
drug resistance (2) 2
drug therapy (2) 2
drugs (2) 2
ebola (2) 2
epidemics (2) 2
epidemiology (2) 2
health (2) 2
health facilities (2) 2
hemorrhagic fever, ebola - diagnosis (2) 2
hemorrhagic fever, ebola - epidemiology (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Lancet, ISSN 0140-6736, 03/2019, Volume 393, Issue 10174, pp. 936 - 948
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2017, Volume 12, Issue 11, p. e0185348
Background Although HIV disease stage at ART initiation critically determines ART outcomes, few reports have longitudinally monitored this within Asia. Using... 
SOUTH-AFRICA | SCALE-UP | THERAPY | MULTIDISCIPLINARY SCIENCES | EXPANSION | FAILURE | PROGRAM | CARE | HIV-INFECTED PATIENTS | Highly active antiretroviral therapy | Usage | Research | Demographic aspects | Drug therapy | HIV infection
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0178577
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, pp. e88552 - e88552
Background: Despite the high burden, there is a dearth of (long-term) outcome data of hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infected patients... 
MORTALITY | IMPACT | RESOURCE-LIMITED SETTINGS | THERAPY | METAANALYSIS | MULTIDISCIPLINARY SCIENCES | IMMUNE RECOVERY | HCV COINFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | NAT COHORT | DISEASE PROGRESSION | Lamivudine - administration & dosage | Cambodia | Humans | Middle Aged | Male | Stavudine - administration & dosage | Zidovudine - administration & dosage | Hepatitis B - complications | Liver - drug effects | Adult | Female | HIV Infections - mortality | Hepatitis C - complications | Retrospective Studies | Anti-Retroviral Agents - therapeutic use | Benzoxazines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | CD4 Lymphocyte Count | Coinfection - virology | HIV Infections - complications | HIV Infections - drug therapy | Nevirapine - administration & dosage | Antiviral agents | Care and treatment | Mortality | HIV patients | HIV (Viruses) | Evidence-based medicine | Infection | Highly active antiretroviral therapy | Analysis | Adults | Hepatitis C virus | HIV infection | Hepatitis B | Antiretroviral drugs | Statistical analysis | Cell survival | Nevirapine | Toxicity | Liver | Viruses | Systematic review | Infections | Regression analysis | Recovery | Efavirenz | CD4 antigen | Tenofovir | Hepatitis | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Hepatitis B virus | Hepatitis C | Index Medicus | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article